| Title： | Patient Version of Guideline for Non-Pharmacological Interventions in Breast Cancer |
| Edition： | Original |
| Classification： | Patient version of guideline |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | The intended users of the guideline include patients with BC, their family members and caregivers, health professionals, policymakers in the medical field, educators, journalists, and other public organizations related to breast cancer management. |
| Evidence classification method： | The GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach will be used to grade the quality of the evidence derived from systematic reviews and make recommendations. |
| Development unit： | Nanfang Nursing Centre of Evidence-based Practice: A JBI Centre of Excellence in Guangzhou, China |
| Registration time: | 2024-04-23 |
| Registration number： | PREPARE-2024CN575 |
| Purpose of the guideline: | To further enhance understanding among patients and the public regarding non-pharmacological interventions for BC, foster enhanced doctor-patient communication and shared decision-making, and promote public health literacy, it is imperative to formulate a patient-centric guideline for non-pharmacological interventions in BC. This guideline aims to provide timely and reliable suggestions for non-pharmacologic interventions in breast cancer to help patients with BC acquire knowledge about the disease, improve self-management ability, prevent adverse outcomes, and alleviate the psychological burden of the disease. |
